海辰药业：第五届董事会第二次会议决议公告

Core Viewpoint - The company, Hai Chen Pharmaceutical, announced the approval of its 2025 semi-annual report and several other proposals during the second meeting of its fifth board of directors [2] Group 1 - The company held its fifth board of directors' second meeting on August 22 [2] - The meeting resulted in the approval of the full text and summary of the 2025 semi-annual report [2]